Obiettivo
The safety and efficacy of bone marrow transplantation using donors other than human leucocyte antigen (HLA) identical siblings was investigated. The results of analyses conducted are preliminary. Nonetheless a substantial proportion of leukemia patients were disease free, alive and well following transplantation of HLA incompatible bone marrow donated by family members.
Campo scientifico
Argomento(i)
Data not availableInvito a presentare proposte
Data not availableMeccanismo di finanziamento
CSC - Cost-sharing contractsCoordinatore
8701 MILWAUKEE
Stati Uniti